home / stock / cycc / cycc short
Short Information | Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 576,936 |
Total Actual Volume | 2,504,761 |
Short Trends | |
---|---|
Cover Days | 19 |
Short Days | 0 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 28,847 |
Average Short Percentage | 17.95% |
Is there a CYCC Short Squeeze or Breakout about to happen?
See the CYCC Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-02-2024 | $1.67 | $1.66 | $1.67 | $1.6 | 14,085 | 355 | 2.52% |
07-01-2024 | $1.66 | $1.62 | $1.72 | $1.57 | 65,492 | 4,112 | 6.28% |
06-28-2024 | $1.74 | $1.62 | $1.75 | $1.5533 | 74,079 | 3,452 | 4.66% |
06-27-2024 | $1.79 | $1.7 | $1.8398 | $1.6492 | 141,021 | 31,217 | 22.14% |
06-26-2024 | $1.72 | $1.9005 | $2 | $1.68 | 942,841 | 265,594 | 28.17% |
06-25-2024 | $1.67 | $1.59 | $1.74 | $1.55 | 59,952 | 6,353 | 10.6% |
06-24-2024 | $1.73 | $1.6624 | $1.8 | $1.6401 | 48,078 | 4,687 | 9.75% |
06-21-2024 | $1.63 | $1.75 | $1.83 | $1.62 | 232,813 | 69,480 | 29.84% |
06-20-2024 | $1.53 | $1.65 | $1.6999 | $1.48 | 75,133 | 24,941 | 33.2% |
06-18-2024 | $1.59 | $1.5 | $1.63 | $1.45 | 56,790 | 16,327 | 28.75% |
06-17-2024 | $1.69 | $1.63 | $1.69 | $1.55 | 38,591 | 12,430 | 32.21% |
06-14-2024 | $1.7 | $1.69 | $1.71 | $1.6509 | 26,509 | 7,181 | 27.09% |
06-13-2024 | $1.68 | $1.65 | $1.77 | $1.65 | 60,170 | 4,879 | 8.11% |
06-12-2024 | $1.8 | $1.7 | $1.8 | $1.68 | 105,519 | 18,148 | 17.2% |
06-11-2024 | $1.87 | $1.85 | $1.9988 | $1.82 | 30,307 | 5,987 | 19.75% |
06-10-2024 | $1.94 | $1.88 | $2.07 | $1.85 | 154,912 | 57,925 | 37.39% |
06-07-2024 | $1.95 | $2 | $2.03 | $1.95 | 57,204 | 3,485 | 6.09% |
06-06-2024 | $2.09 | $1.98 | $2.15 | $1.95 | 62,701 | 5,611 | 8.95% |
06-05-2024 | $2.17 | $2.12 | $2.19 | $2.05 | 81,385 | 10,000 | 12.29% |
06-04-2024 | $2.12 | $2.17 | $2.38 | $2 | 177,179 | 24,772 | 13.98% |
News, Short Squeeze, Breakout and More Instantly...
Cyclacel Pharmaceuticals Inc. Company Name:
CYCC Stock Symbol:
NASDAQ Market:
Cyclacel Pharmaceuticals Inc. Website:
BERKELEY HEIGHTS, N.J., June 26, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced the receipt of a notice from the European ...
- Novel CDK2/9 inhibitor fadraciclib induces anaphase catastrophe, a novel cancer-specific mechanism of action - BERKELEY HEIGHTS, N.J., June 04, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”...
- Clinical, PK and PD data from novel CDK2/9 inhibitor fadraciclib monotherapy studies support ongoing proof of concept study in patients with solid tumors and lymphoma - BERKELEY HEIGHTS, N.J., June 03, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP;...